Ewing sarcoma

Seminars in Diagnostic Pathology

Volumn 31, Issue 1, 2014, Pages 39-47

  Choi, Eun Young K ^a   Gardner, Jerad M ^b   Lucas, David R ^a   McHugh, Jonathan B ^a   Patel, Rajiv M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Ewing family of tumors; Ewing sarcoma; Ewing like sarcoma; Primitive neuroectodermal tumor; Small round cell sarcoma

Indexed keywords

CD99 ANTIGEN; CYTOKERATIN 19; CYTOKERATIN 7; CYTOKERATIN AE1; CYTOKERATIN AE3; DESMIN; KERATIN; MYOD1 PROTEIN; TRANSCRIPTION FACTOR FLI 1; TRANSCRIPTION FACTOR NKX2.2; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR PAX7;

AGE DISTRIBUTION; ARTICLE; BONE TUMOR; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EWING SARCOMA; GENE REARRANGEMENT; GENE TRANSLOCATION; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMMUNOPHENOTYPING; MERKEL CELL TUMOR; MESENCHYME CHONDROSARCOMA; MOLECULAR PATHOLOGY; NEUROBLASTOMA; PATHOPHYSIOLOGY; PRIMARY BONE LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; RHABDOMYOSARCOMA; SEX DIFFERENCE; SMALL CELL CARCINOMA; SMALL CELL OSTEOSARCOMA; SYNOVIAL SARCOMA;

EWING FAMILY OF TUMORS; EWING SARCOMA; EWING-LIKE SARCOMA; PRIMITIVE NEUROECTODERMAL TUMOR; SMALL ROUND CELL SARCOMA;

BONE NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; HUMANS; NEUROECTODERMAL TUMORS, PRIMITIVE; PATHOLOGY, MOLECULAR; PROGNOSIS; SARCOMA, EWING;

EID: 84896949659     PISSN: 07402570     EISSN: 19301111     Source Type: Journal    
DOI: 10.1053/j.semdp.2014.01.002     Document Type: Article

References (62)

1. Esiashvili N., Goodman M., Marcus R.B. Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: Surveillance Epidemiology and End Results data. J Pediatr Hematol Oncol 2008, 30(6):425-430.
2. Mascarenhas L., Siegel S., Spector L., Arndt C., Femino D., Malogolowkin M. Malignant bone tumors. Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975-2000 2006, 97-109. National Cancer Institute, Bethesda, MD. A. Bleyer, M. O'Leary, R. Barr (Eds.).
3. Jawad M.U., Cheung M.C., Min E.S., Schneiderbauer M.M., Koniaris L.G., Scully S.P. Ewing sarcoma demonstrates racial disparities in incidence-related and sex-related differences in outcome: an analysis of 1631 cases from the SEER database, 1973-2005. Cancer 2009, 115(15):3526-3536.
4. Applebaum M.A., Worch J., Matthay K.K., et al. Clinical features and outcomes in patients with extraskeletal Ewing sarcoma. Cancer 2011, 117(13):3027-3032.
5. Cotterill S.J., Ahrens S., Paulussen M., et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 2000, 18(17):3108-3114.
6. Lawlor E.R., Lim J.F., Tao W., et al. The Ewing tumor family of peripheral primitive neuroectodermal tumors expresses human gastrin-releasing peptide. Cancer Res 1998, 58(11):2469-2476.
7. O'Regan S., Diebler M.F., Meunier F.M., Vyas S. A Ewing's sarcoma cell line showing some, but not all, of the traits of a cholinergic neuron. J Neurochem 1995, 64(1):69-76.
8. Tirode F., Laud-Duval K., Prieur A., Delorme B., Charbord P., Delattre O. Mesenchymal stem cell features of Ewing tumors. Cancer Cell 2007, 11(5):421-429.
9. Widhe B., Widhe T. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am 2000, 82(5):667-674.
10. Stoker D.J., Saifuddin A. Bone tumours (2): malignant lesions. Grainger & Allison's Diagnostic Radiology: A Textbook of Medical Imaging 2008, 1059-1081. Churchill Livingstone, Edinburgh. A. Adam, A.K. Dixon (Eds.).
11. Parham D.M., Hijazi Y., Steinberg S.M., et al. Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior. Hum Pathol 1999, 30(8):911-918.
12. Folpe A.L., Goldblum J.R., Rubin B.P., et al. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol 2005, 29(8):1025-1033.
13. Nascimento A.G., Unii K.K., Pritchard D.J., Cooper K.L., Dahlin D.C. A clinicopathologic study of 20 cases of large-cell (atypical) Ewing's sarcoma of bone. Am J Surg Pathol 1980, 4(1):29-36.
14. Llombart-Bosch A., Machado I., Navarro S., et al. Histological heterogeneity of Ewing's sarcoma/PNET: an immunohistochemical analysis of 415 genetically confirmed cases with clinical support. Virchows Arch 2009, 455(5):397-411.
15. Machado I., Noguera R., Mateos E.A., et al. The many faces of atypical Ewing's sarcoma. A true entity mimicking sarcomas, carcinomas and lymphomas. Virchows Arch 2011, 458(3):281-290.
16. Fujii H., Honoki K., Enomoto Y., et al. Adamantinoma-like Ewing's sarcoma with EWS-FLI1 fusion gene: a case report. Virchows Arch 2006, 449(5):579-584.
17. Ozdemirli M., Fanburg-Smith J.C., Hartmann D.P., Azumi N., Miettinen M. Differentiating lymphoblastic lymphoma and Ewing's sarcoma: lymphocyte markers and gene rearrangement. Mod Pathol 2001, 14(11):1175-1182.
18. Granter S.R., Renshaw A.A., Fletcher C.D., Bhan A.K., Rosenberg A.E. CD99 reactivity in mesenchymal chondrosarcoma. Hum Pathol 1996, 27(12):1273-1276.
19. Lae M.E., Roche P.C., Jin L., Lloyd R.V., Nascimento A.G. Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am J Surg Pathol 2002, 26(7):823-835.
20. Devaney K., Abbondanzo S.L., Shekitka K.M., Wolov R.B., Sweet D.E. MIC2 detection in tumors of bone and adjacent soft tissues. Clin Orthop Relat Res 1995, (310):176-187.
21. Riopel M., Dickman P.S., Link M.P., Perlman E.J. MIC2 analysis in pediatric lymphomas and leukemias. Hum Pathol 1994, 25(4):396-399.
22. Machado I., Alberghini M., Giner F., et al. Histopathological characterization of small cell osteosarcoma with immunohistochemistry and molecular genetic support. A study of 10 cases. Histopathology 2010, 57(1):162-167.
23. Carter R.L., al-Sams S.Z., Corbett R.P., Clinton S. A comparative study of immunohistochemical staining for neuron-specific enolase, protein gene product 9.5 and S-100 protein in neuroblastoma, Ewing's sarcoma and other round cell tumours in children. Histopathology 1990, 16(5):461-467.
24. Folpe A.L., Hill C.E., Parham D.M., O'Shea P.A., Weiss S.W. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol 2000, 24(12):1657-1662.
25. Rossi S., Orvieto E., Furlanetto A., Laurino L., Ninfo V., Dei Tos A.P. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol 2004, 17(5):547-552.
26. Lin O., Filippa D.A., Teruya-Feldstein J. Immunohistochemical evaluation of FLI-1 in acute lymphoblastic lymphoma (ALL): a potential diagnostic pitfall. Appl Immunohistochem Mol Morphol 2009, 17(5):409-412.
27. Wang W.L., Patel N.R., Caragea M., et al. Expression of ERG, an Ets family transcription factor, identifies ERG-rearranged Ewing sarcoma. Mod Pathol 2012, 25(10):1378-1383.
28. Yoshida A., Sekine S., Tsuta K., Fukayama M., Furuta K., Tsuda H. NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma. Am J Surg Pathol 2012, 36(7):993-999.
29. Machado I., Navarro S., Lopez-Guerrero J.A., Alberghini M., Picci P., Llombart-Bosch A. Epithelial marker expression does not rule out a diagnosis of Ewing's sarcoma family of tumours. Virchows Arch 2011, 459(4):409-414.
30. Gu M., Antonescu C.R., Guiter G., Huvos A.G., Ladanyi M., Zakowski M.F. Cytokeratin immunoreactivity in Ewing's sarcoma: prevalence in 50 cases confirmed by molecular diagnostic studies. Am J Surg Pathol 2000, 24(3):410-416.
31. Parham D.M., Dias P., Kelly D.R., Rutledge J.C., Houghton P. Desmin positivity in primitive neuroectodermal tumors of childhood. Am J Surg Pathol 1992, 16(5):483-492.
32. Delattre O., Zucman J., Plougastel B., et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992, 359(6391):162-165.
33. de Alava E., Lessnick S.L., Sorensen P.H. Ewing Sarcoma. WHO Classification of Tumours of Soft Tissue and Bone 2013, 306-309. IARC Press, Lyon. C.D.M. Fletcher, J.A. Bridge, P.C. Hogendoorn (Eds.).
34. de Alava E., Pardo J. Ewing tumor: tumor biology and clinical applications. Int J Surg Pathol 2001, 9(1):7-17.
35. Delattre O., Zucman J., Melot T., et al. The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 1994, 331(5):294-299.
36. Sorensen P.H., Lessnick S.L., Lopez-Terrada D., Liu X.F., Triche T.J., Denny C.T. A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet 1994, 6(2):146-151.
37. Jeon I.S., Davis J.N., Braun B.S., et al. A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene 1995, 10(6):1229-1234.
38. Kaneko Y., Yoshida K., Handa M., et al. Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy. Genes Chromosomes Cancer 1996, 15(2):115-121.
39. Peter M., Couturier J., Pacquement H., et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene 1997, 14(10):1159-1164.
40. Armengol G., Tarkkanen M., Virolainen M., et al. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumours by comparative genomic hybridization. Br J Cancer 1997, 75(10):1403-1409.
41. Shing D.C., McMullan D.J., Roberts P., et al. FUS/ERG gene fusions in Ewing's tumors. Cancer Res 2003, 63(15):4568-4576.
42. Berg T., Kalsaas A.H., Buechner J., Busund L.T. Ewing sarcoma-peripheral neuroectodermal tumor of the kidney with a FUS-ERG fusion transcript. Cancer Genet Cytogenet 2009, 194(1):53-57.
43. Ng T.L., O'Sullivan M.J., Pallen C.J., et al. Ewing sarcoma with novel translocation t(2;16) producing an in-frame fusion of FUS and FEV. J Mol Diagn 2007, 9(4):459-463.
44. Pierron G., Tirode F., Lucchesi C., et al. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet 2012, 44(4):461-466.
45. Linabery A.M., Ross J.A. Childhood and adolescent cancer survival in the US by race and ethnicity for the diagnostic period 1975-1999. Cancer 2008, 113(9):2575-2596.
46. Ludwig J.A. Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future. Curr Opin Oncol 2008, 20(4):412-418.
47. Picci P., Bohling T., Bacci G., et al. Chemotherapy-induced tumor necrosis as a prognostic factor in localized Ewing's sarcoma of the extremities. J Clin Oncol 1997, 15(4):1553-1559.
48. Nakashima Y., Unni K.K., Shives T.C., Swee R.G., Dahlin D.C. Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer 1986, 57(12):2444-2453.
49. Nakajima H., Sim F.H., Bond J.R., Unni K.K. Small cell osteosarcoma of bone. Review of 72 cases. Cancer 1997, 79(11):2095-2106.
50. Somers G.R., Shago M., Zielenska M., Chan H.S., Ngan B.Y. Primary subcutaneous primitive neuroectodermal tumor with aggressive behavior and an unusual karyotype: case report. Pediatr Dev Pathol 2004, 7(5):538-545.
51. Choi E.Y., Thomas D.G., McHugh J.B., et al. Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology. Am J Surg Pathol 2013, 37(9):1379-1386.
52. Graham C., Chilton-MacNeill S., Zielenska M., Somers G.R. The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas. Hum Pathol 2012, 43(2):180-189.
53. Italiano A., Sung Y.S., Zhang L., et al. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer 2012, 51(3):207-218.
54. Kajtar B., Tornoczky T., Kalman E., Kuzsner J., Hogendoorn P.C., Szuhai K. CD99-positive undifferentiated round cell sarcoma diagnosed on fine needle aspiration cytology, later found to harbour a CIC-DUX4 translocation: a recently described entity. Cytopathology 2013, http://onlinelibrary.wiley.com/doi/10.1111/cyt.12079/abstract;jsessionid=0D364C52932E67456AAEFD5DBCE8C014.f02t03 [E-pub ahead of print].
55. Kawamura-Saito M., Yamazaki Y., Kaneko K., et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet 2006, 15(13):2125-2137.
56. Machado I., Cruz J., Lavernia J., et al. Superficial EWSR1-negative undifferentiated small round cell sarcoma with CIC/DUX4 gene fusion: a new variant of Ewing-like tumors with locoregional lymph node metastasis. Virchows Arch 2013, 463(6):837-842.
57. Rakheja D., Goldman S., Wilson K.S., Lenarsky C., Weinthal J., Schultz R.A. Translocation (4;19)(q35;q13.1)-associated primitive round cell sarcoma: report of a case and review of the literature. Pediatr Dev Pathol 2008, 11(3):239-244.
58. Richkind K.E., Romansky S.G., Finklestein J.Z. t(4;19)(q35;q13.1): a recurrent change in primitive mesenchymal tumors?. Cancer Genet Cytogenet 1996, 87(1):71-74.
59. Yoshimoto M., Graham C., Chilton-MacNeill S., et al. Detailed cytogenetic and array analysis of pediatric primitive sarcomas reveals a recurrent CIC-DUX4 fusion gene event. Cancer Genet Cytogenet 2009, 195(1):1-11.
60. Jung S.C., Choi J.A., Chung J.H., Oh J.H., Lee J.W., Kang H.S. Synovial sarcoma of primary bone origin: a rare case in a rare site with atypical features. Skeletal Radiol 2007, 36(1):67-71.
61. Lucas D.R., Ryan J.R., Zalupski M.M., Gross M.L., Ravindranath Y., Ortman B. Primary embryonal rhabdomyosarcoma of long bone. Case report and review of the literature. Am J Surg Pathol 1996, 20(2):239-244.
62. Murphy A., Stallings R.L., Howard J., et al. Primary desmoplastic small round cell tumor of bone: report of a case with cytogenetic confirmation. Cancer Genet Cytogenet 2005, 156(2):167-171.